{"id":7237,"date":"2025-07-02T18:20:55","date_gmt":"2025-07-02T23:20:55","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=7237"},"modified":"2025-07-13T15:09:02","modified_gmt":"2025-07-13T20:09:02","slug":"nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ar\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/","title":{"rendered":"\u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633 \u0633\u062a\u0639\u0631\u0636 \u0623\u0628\u062d\u0627\u062b\u0627\u064b \u0631\u0627\u0626\u062f\u0629 \u0641\u064a \u0627\u0644\u0627\u062c\u062a\u0645\u0627\u0639 \u0627\u0644\u0633\u0646\u0648\u064a \u0644\u0644\u062c\u0645\u0639\u064a\u0629 \u0627\u0644\u0623\u0645\u0631\u064a\u0643\u064a\u0629 \u0644\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u062c\u064a\u0646\u064a \u0648\u0627\u0644\u062e\u0644\u0648\u064a 2025"},"content":{"rendered":"<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"row\">\n<div class=\"col-sm-12\">\n<div class=\"row detail-headline\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n<h2 class=\"prntac\" style=\"text-align: center;\"><i>Presentations will highlight durability, efficacy and safety of\u00a0Nanoscope&#8217;s optogenetic therapy platforms<\/i><\/h2>\n<\/div>\n<div class=\"col-sm-4 col-xs-12 col-vcenter\">\n<div class=\"image logo logo-wrapper\" data-src=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=publish\" data-asset-type=\"photo\" data-asset-label=\"Logo\" data-download-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg\" data-tweet-text=\"Nanoscope Therapeutics Logo (PRNewsfoto\/Nanoscope Therapeutics)\" data-pinterest-text=\"Nanoscope Therapeutics Logo (PRNewsfoto\/Nanoscope Therapeutics)\" data-linkedin-text=\"Nanoscope Therapeutics Logo (PRNewsfoto\/Nanoscope Therapeutics)\" data-facebook-share-text=\"Nanoscope Therapeutics Logo (PRNewsfoto\/Nanoscope Therapeutics)\" data-twitter-share-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=twitter\" data-facebook-share-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=facebook\" data-pinterest-share-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=publish\" data-linkedin-share-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=linkedin\">\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">\u062f\u0627\u0644\u0627\u0633<\/span><\/span>,\u00a0<span class=\"legendSpanClass\"><span class=\"xn-chron\">12 \u0645\u0627\u064a\u0648 2025<\/span><\/span>\u00a0\/ \u0628\u064a \u0622\u0631 \u0646\u064a\u0648\u0632\u0648\u0627\u064a\u0631 \/ \u2014\u00a0<a href=\"http:\/\/nanostherapeutics.com\/ar\/\" target=\"_blank\" rel=\"nofollow noopener\">\u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u0644\u0644\u0639\u0644\u0627\u062c\u0627\u062a<\/a>, \u0623\u0639\u0644\u0646\u062a \u0634\u0631\u0643\u0629 \u0627\u0644\u062a\u0643\u0646\u0648\u0644\u0648\u062c\u064a\u0627 \u0627\u0644\u062d\u064a\u0648\u064a\u0629\u060c \u0627\u0644\u0645\u0644\u062a\u0632\u0645\u0629 \u0628\u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631 \u0644\u062f\u0649 \u0627\u0644\u0645\u0631\u0636\u0649 \u0627\u0644\u0645\u0643\u0641\u0648\u0641\u064a\u0646 \u0641\u064a \u0628\u064a\u0626\u0627\u062a \u0648\u0627\u0642\u0639\u064a\u0629 \u0645\u0646 \u062e\u0644\u0627\u0644 \u062a\u0637\u0648\u064a\u0631 \u0648\u062a\u0633\u0648\u064a\u0642 \u0639\u0644\u0627\u062c\u0627\u062a \u062c\u064a\u0646\u064a\u0629 \u062c\u062f\u064a\u062f\u0629 \u0644\u0623\u0645\u0631\u0627\u0636 \u062a\u0646\u0643\u0633 \u0627\u0644\u0634\u0628\u0643\u064a\u0629\u060c \u0627\u0644\u064a\u0648\u0645 \u0639\u0646 \u062a\u0642\u062f\u064a\u0645 \u0639\u0631\u0648\u0636 \u0645\u062a\u0639\u062f\u062f\u0629 \u0641\u064a \u0627\u0644\u0645\u0624\u062a\u0645\u0631 \u0627\u0644\u062b\u0627\u0645\u0646 \u0648\u0627\u0644\u0639\u0634\u0631\u064a\u0646<sup>\u0630<\/sup>\u00a0\u0627\u0644\u0627\u062c\u062a\u0645\u0627\u0639 \u0627\u0644\u0633\u0646\u0648\u064a \u0644\u0644\u062c\u0645\u0639\u064a\u0629 \u0627\u0644\u0623\u0645\u0631\u064a\u0643\u064a\u0629 \u0644\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u062c\u064a\u0646\u064a \u0648\u0627\u0644\u062e\u0644\u0648\u064a (<a href=\"https:\/\/annualmeeting.asgct.org\/?gad_source=1&amp;gad_campaignid=22011672452&amp;gbraid=0AAAAADHZ2HQnr1TF8BjiisdZLSvQ1L5fH&amp;gclid=Cj0KCQjwrPHABhCIARIsAFW2XBOyOPUxQcyc0OwCQ59sxmSlG0uS4eBLOykckVLfPmHO9pLdEk1Gv2waAqPOEALw_wcB\" target=\"_blank\" rel=\"nofollow noopener\">\u0645\u0624\u062a\u0645\u0631 \u0627\u0644\u062c\u0645\u0639\u064a\u0629 \u0627\u0644\u0623\u0645\u0631\u064a\u0643\u064a\u0629 \u0644\u0639\u0644\u0645 \u0627\u0644\u062e\u0644\u0627\u064a\u0627 \u0627\u0644\u062c\u0631\u062b\u0648\u0645\u064a\u0629 2025<\/a>\u0633\u064a\u064f\u0639\u0642\u062f \u0641\u064a \u0645\u0631\u0643\u0632 \u0625\u0631\u0646\u0633\u062a \u0625\u0646. \u0645\u0648\u0631\u064a\u0627\u0644 \u0644\u0644\u0645\u0624\u062a\u0645\u0631\u0627\u062a \u0641\u064a\u00a0<span class=\"xn-location\">\u0646\u064a\u0648 \u0623\u0648\u0631\u0644\u064a\u0627\u0646\u0632<\/span>,\u00a0<span class=\"xn-chron\">13-17 \u0645\u0627\u064a\u0648<\/span><sup>\u0630<\/sup>, 2025.\u00a0 Nanoscope&#8217;s presentations will be centered around the company&#8217;s\u00a0<a href=\"https:\/\/nanostherapeutics.com\/ar\/technology-2\/\" target=\"_blank\" rel=\"nofollow noopener\">\u0627\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u0628\u0635\u0631\u064a \u0627\u0644\u0648\u0631\u0627\u062b\u064a MCO-010<\/a>\u00a0\u0644\u0639\u0644\u0627\u062c \u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u062a\u0646\u0643\u0633 \u0627\u0644\u0634\u0628\u0643\u064a. \u064a\u064f\u0639\u062f\u0651 MCO-010 \u0627\u0644\u0628\u0631\u0646\u0627\u0645\u062c \u0627\u0644\u0623\u0643\u062b\u0631 \u062a\u0637\u0648\u0631\u064b\u0627 \u0641\u064a \u0645\u0646\u0635\u0629 MCO (\u0627\u0644\u0623\u0648\u0628\u0633\u064a\u0646 \u0645\u062a\u0639\u062f\u062f \u0627\u0644\u062e\u0635\u0627\u0626\u0635)\u060c \u0648\u0647\u0648 \u0627\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u0623\u0648\u0644 \u0648\u0627\u0644\u0648\u062d\u064a\u062f \u0627\u0644\u0630\u064a \u0644\u0627 \u064a\u0639\u062a\u0645\u062f \u0639\u0644\u0649 \u0646\u0648\u0639 \u0627\u0644\u0637\u0641\u0631\u0629.\u00a0<a href=\"https:\/\/www.cell.com\/molecular-therapy-family\/molecular-therapy\/fulltext\/S1525-0016(25)00205-9\" target=\"_blank\" rel=\"nofollow noopener\">\u062b\u0628\u062a \u0623\u0646\u0647\u0627 \u062a\u0639\u064a\u062f \u0627\u0644\u0628\u0635\u0631 \u0644\u062f\u0649 \u0645\u0631\u0636\u0649 \u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0635\u0628\u0627\u063a\u064a \u0627\u0644\u0645\u062a\u0642\u062f\u0645<\/a>\u00a0\u0639\u0646 \u0637\u0631\u064a\u0642 \u062d\u0642\u0646\u0629 \u0648\u0627\u062d\u062f\u0629 \u0642\u064a\u0627\u0633\u064a\u0629 \u062f\u0627\u062e\u0644 \u0627\u0644\u062c\u0633\u0645 \u0627\u0644\u0632\u062c\u0627\u062c\u064a.<\/p>\n<p>&#8220;We are excited to present the safety and efficacy results of our MCO therapy for multiple retinal diseases, including Stargardt macular degeneration in clinical trials, and geographic atrophy in non-human primate models,&#8221; said Dr.\u00a0<span class=\"xn-person\">\u0633\u0627\u0645\u0627\u0631\u0646\u062f\u0631\u0627 \u0645\u0648\u0647\u0627\u0646\u062a\u064a<\/span>, co-founder and President of Nanoscope. &#8220;<b>\u0628\u0627\u0644\u0625\u0636\u0627\u0641\u0629 \u0625\u0644\u0649 \u062a\u0642\u062f\u064a\u0645 \u0641\u062d\u0648\u0635\u0627\u062a \u0642\u0648\u064a\u0629 \u0644\u0636\u0645\u0627\u0646 \u0641\u0639\u0627\u0644\u064a\u0629 MCO-010<\/b>, \u0646\u062a\u0637\u0644\u0639 \u0625\u0644\u0649 \u0645\u0634\u0627\u0631\u0643\u0629 \u062a\u0641\u0627\u0635\u064a\u0644 \u062d\u0648\u0644 \u0627\u0644\u0641\u0648\u0627\u0626\u062f \u0627\u0644\u0639\u0644\u0627\u062c\u064a\u0629 \u0627\u0644\u0625\u064a\u062c\u0627\u0628\u064a\u0629 \u0627\u0644\u062a\u064a \u0644\u0648\u062d\u0638\u062a \u0644\u062f\u0649 \u0645\u0631\u0636\u0649 \u0633\u062a\u0627\u0631\u063a\u0627\u0631\u062f\u062a\u060c \u0648\u0627\u0644\u062a\u064a \u0643\u0627\u0646\u062a \u0645\u0645\u0627\u062b\u0644\u0629 \u0644\u0644\u0641\u0648\u0627\u0626\u062f \u0637\u0648\u064a\u0644\u0629 \u0627\u0644\u0623\u0645\u062f\u00a0<b>\u062a\u062d\u0633\u0646 \u0627\u0644\u0631\u0624\u064a\u0629 \u0644\u062f\u0649 \u0627\u0644\u0645\u0631\u0636\u0649 \u0627\u0644\u0645\u0635\u0627\u0628\u064a\u0646 \u0628\u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0635\u0628\u0627\u063a\u064a (RP).\u00a0<\/b>It is an exciting time at Nanoscope as we prepare MCO-010 for commercialization, including BLA submission.&#8221;<\/p>\n<p>\u0641\u064a\u0645\u0627 \u064a\u0644\u064a \u062a\u0641\u0627\u0635\u064a\u0644 \u0639\u0631\u0648\u0636 \u0627\u0644\u0627\u062c\u062a\u0645\u0627\u0639:<\/p>\n<p><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4425505-1&amp;h=1073963099&amp;u=https%3A%2F%2Fannualmeeting.asgct.org%2Fprogram&amp;a=Full+Agenda\" target=\"_blank\" rel=\"nofollow noopener\">\u062c\u062f\u0648\u0644 \u0627\u0644\u0623\u0639\u0645\u0627\u0644 \u0627\u0644\u0643\u0627\u0645\u0644<\/a><\/p>\n<p>\u0627\u0644\u0639\u0631\u0648\u0636 \u0627\u0644\u062a\u0642\u062f\u064a\u0645\u064a\u0629 \u0639\u0644\u0649 \u0627\u0644\u0645\u0646\u0635\u0629:<\/p>\n<ul type=\"disc\">\n<li><b><span class=\"xn-chron\">\u0627\u0644\u062b\u0644\u0627\u062b\u0627\u0621\u060c 13 \u0645\u0627\u064a\u0648<\/span><sup>\u0630<\/sup>, 2:15 \u0645\u0633\u0627\u0621\u064b \u2013\u00a0<span class=\"xn-chron\">2:30 \u0645\u0633\u0627\u0621\u064b<\/span>;\u00a0<i>\u0627\u0644\u063a\u0631\u0641\u0629 265-268<\/i>\u00a0<\/b>- \u062f\u0643\u062a\u0648\u0631.\u00a0<span class=\"xn-person\">\u0633\u0627\u0645\u0627\u0631\u0646\u062f\u0631\u0627 \u0645\u0648\u0647\u0627\u0646\u062a\u064a<\/span>\u00a0presenting \u2013 &#8220;<i>\u0633\u0644\u0627\u0645\u0629 \u0648\u0641\u0639\u0627\u0644\u064a\u0629 \u0627\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u062c\u064a\u0646\u064a \u0645\u062a\u0639\u062f\u062f \u0627\u0644\u062e\u0635\u0627\u0626\u0635 \u0644\u0644\u0623\u0648\u0628\u0633\u064a\u0646 \u0641\u064a \u062a\u062d\u0633\u064a\u0646 \u0627\u0644\u0631\u0624\u064a\u0629 \u0641\u064a \u0646\u0645\u0648\u0630\u062c \u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0627\u062a \u063a\u064a\u0631 \u0627\u0644\u0628\u0634\u0631\u064a\u0629 \u0627\u0644\u0645\u0635\u0627\u0628\u0629 \u0628\u0627\u0644\u0636\u0645\u0648\u0631 \u0627\u0644\u062c\u063a\u0631\u0627\u0641\u064a<\/i>&#8220;<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li><b><span class=\"xn-chron\">\u0627\u0644\u062b\u0644\u0627\u062b\u0627\u0621\u060c 13 \u0645\u0627\u064a\u0648<\/span><sup>\u0630<\/sup>,\u00a0<span class=\"xn-chron\">2:30 \u0645\u0633\u0627\u0621\u064b<\/span>\u00a0-\u00a0<span class=\"xn-chron\">2:45 \u0645\u0633\u0627\u0621\u064b<\/span>;\u00a0<i>\u0627\u0644\u063a\u0631\u0641\u0629 288-290<\/i>\u00a0<\/b>- \u062f\u0643\u062a\u0648\u0631.\u00a0<span class=\"xn-person\">\u0633\u0648\u0631\u0627\u0641 \u0645\u0648\u0647\u0627\u0646\u062a\u064a<\/span>\u00a0presenting \u2013 &#8220;<i>\u0627\u0644\u0633\u0644\u0627\u0645\u0629\u060c \u0648\u0627\u0644\u062a\u062d\u0645\u0644\u060c \u0648\u0627\u0644\u062a\u0648\u0632\u064a\u0639 \u0627\u0644\u062d\u064a\u0648\u064a\u060c \u0648\u0627\u0644\u062a\u0639\u0628\u064a\u0631 \u0627\u0644\u062c\u064a\u0646\u064a\u060c \u0648\u0641\u0639\u0627\u0644\u064a\u0629 \u0627\u0644\u062a\u0648\u0635\u064a\u0644 \u0627\u0644\u0645\u0648\u062c\u0647 \u063a\u064a\u0631 \u0627\u0644\u0641\u064a\u0631\u0648\u0633\u064a \u0627\u0644\u0642\u0627\u0626\u0645 \u0639\u0644\u0649 \u0627\u0644\u0644\u064a\u0632\u0631 \u0648\u0627\u0644\u0645\u0648\u062c\u0647 \u0628\u0627\u0644\u0635\u0648\u0631 \u0644\u0644\u0623\u0648\u0628\u0633\u064a\u0646 \u0645\u062a\u0639\u062f\u062f \u0627\u0644\u062e\u0635\u0627\u0626\u0635 \u0641\u064a \u0634\u0628\u0643\u064a\u0629 \u0639\u064a\u0648\u0646 \u0642\u0631\u0648\u062f \u0627\u0644\u0641\u0631\u0641\u062a \u0627\u0644\u0623\u0641\u0631\u064a\u0642\u064a\u0629<\/i>&#8220;<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li><b><span class=\"xn-chron\">\u0627\u0644\u0623\u0631\u0628\u0639\u0627\u0621\u060c 14 \u0645\u0627\u064a\u0648<\/span><sup>\u0630<\/sup>,\u00a0<span class=\"xn-chron\">\u0627\u0644\u0633\u0627\u0639\u0629 \u0627\u0644\u0631\u0627\u0628\u0639\u0629 \u0645\u0633\u0627\u0621\u064b<\/span>\u00a0-\u00a0<span class=\"xn-chron\">4:15 \u0645\u0633\u0627\u0621\u064b<\/span>;\u00a0<i>\u0627\u0644\u063a\u0631\u0641\u0629 265-268<\/i><\/b>- \u062f\u0643\u062a\u0648\u0631.\u00a0<span class=\"xn-person\">\u0633\u0648\u0628\u0631\u0627\u062a\u0627 \u0628\u0627\u062a\u0627\u0628\u0627\u0644<\/span>\u00a0presenting \u2013 &#8220;<i>\u062a\u0637\u0648\u064a\u0631 \u0641\u062d\u0648\u0635\u0627\u062a \u0641\u0639\u0627\u0644\u064a\u0629 \u0645\u062a\u0639\u0627\u0645\u062f\u0629 \u0644\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u062c\u064a\u0646\u064a \u0645\u062a\u0639\u062f\u062f \u0627\u0644\u062e\u0635\u0627\u0626\u0635 \u0644\u0644\u0623\u0648\u0628\u0633\u064a\u0646: \u0627\u0644\u062a\u0639\u0628\u064a\u0631 \u0627\u0644\u062c\u064a\u0646\u064a \u0648\u0627\u0644\u0646\u0634\u0627\u0637 \u0627\u0644\u0645\u062d\u0641\u0632 \u0628\u0627\u0644\u0636\u0648\u0621<\/i>&#8220;<\/li>\n<\/ul>\n<p>\u0627\u0644\u0639\u0631\u0648\u0636 \u0627\u0644\u062a\u0642\u062f\u064a\u0645\u064a\u0629 \u0639\u0644\u0649 \u0634\u0643\u0644 \u0645\u0644\u0635\u0642\u0627\u062a:<\/p>\n<ul type=\"disc\">\n<li><b><span class=\"xn-chron\">\u0627\u0644\u062b\u0644\u0627\u062b\u0627\u0621\u060c 13 \u0645\u0627\u064a\u0648<\/span><sup>\u0630<\/sup>,\u00a0\u00a0<span class=\"xn-chron\">\u0627\u0644\u0633\u0627\u0639\u0629 6:00 \u0645\u0633\u0627\u0621\u064b<\/span>\u00a0-\u00a0<span class=\"xn-chron\">7:30 \u0645\u0633\u0627\u0621\u064b<\/span>;\u00a0<\/b><b>\u0642\u0627\u0639\u0629 \u0627\u0644\u0645\u0644\u0635\u0642\u0627\u062a\u00a0<\/b><b>-<\/b>\u00a0\u062f\u0643\u062a\u0648\u0631.\u00a0<span class=\"xn-person\">\u0641\u064a\u0646\u064a\u062a \u0645\u0627\u0647\u0627\u062c\u0627\u0646<\/span>\u00a0presenting \u2013 &#8220;Human Retinal Cell Delivery of a Bioengineered, Synthetic Protein Sensitive to Multiple Wavelengths of Light in Patients with Stargardt Disease&#8221;, Poster No. 584<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li><b><span class=\"xn-chron\">\u0627\u0644\u0623\u0631\u0628\u0639\u0627\u0621\u060c 14 \u0645\u0627\u064a\u0648<\/span><sup>\u0630<\/sup>,\u00a0<span class=\"xn-chron\">5:30 \u0645\u0633\u0627\u0621\u0627<\/span>\u00a0-\u00a0<span class=\"xn-chron\">\u0627\u0644\u0633\u0627\u0639\u0629 7:00 \u0645\u0633\u0627\u0621\u064b<\/span>;\u00a0<\/b><b>\u0642\u0627\u0639\u0629 \u0627\u0644\u0645\u0644\u0635\u0642\u0627\u062a\u00a0<\/b><b>-<\/b>\u00a0\u062f\u0643\u062a\u0648\u0631.\u00a0<span class=\"xn-person\">\u0623\u0645\u064a\u0631 \u0633\u064a\u0646\u063a<\/span>\u00a0presenting \u2013 &#8220;Forced Degradation Studies of Multi-Characteristic Opsin Gene Therapy Drug Product&#8221;, Poster No. 1380<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li><b><span class=\"xn-chron\">\u0627\u0644\u062e\u0645\u064a\u0633\u060c 15 \u0645\u0627\u064a\u0648<\/span><sup>\u0630<\/sup>,\u00a0<span class=\"xn-chron\">5:30 \u0645\u0633\u0627\u0621\u0627<\/span>\u00a0-\u00a0<span class=\"xn-chron\">\u0627\u0644\u0633\u0627\u0639\u0629 7:00 \u0645\u0633\u0627\u0621\u064b<\/span><\/b>;\u00a0<b>\u0642\u0627\u0639\u0629 \u0627\u0644\u0645\u0644\u0635\u0642\u0627\u062a\u00a0<\/b><b>-<\/b>\u00a0\u062f\u0643\u062a\u0648\u0631.\u00a0<span class=\"xn-person\">\u0623\u0646\u0627\u0646\u062a\u0627 \u0623\u064a\u0627\u062c\u0627\u0631\u064a<\/span>\u00a0presenting \u2013 &#8220;Accelerated Regulatory Approvals in Cell and Gene Therapy&#8221;, Poster No. 1856<\/li>\n<\/ul>\n<p>\u0633\u064a\u0643\u0648\u0646 \u0623\u0639\u0636\u0627\u0621 \u0641\u0631\u064a\u0642 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u0645\u062a\u0627\u062d\u064a\u0646 \u0623\u064a\u0636\u0627\u064b \u0644\u0644\u0627\u062c\u062a\u0645\u0627\u0639\u0627\u062a \u062e\u0644\u0627\u0644 \u0645\u0624\u062a\u0645\u0631 \u0627\u0644\u062c\u0645\u0639\u064a\u0629 \u0627\u0644\u0623\u0645\u0631\u064a\u0643\u064a\u0629 \u0644\u0639\u0644\u0645 \u0627\u0644\u0623\u0648\u0631\u0627\u0645 \u0627\u0644\u0633\u0631\u064a\u0631\u064a \u0648\u0627\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u0643\u064a\u0645\u064a\u0627\u0626\u064a.<\/p>\n<p><b>\u062d\u0648\u0644 \u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u064a\u0643\u0633 \u0625\u0646\u0643.<br class=\"dnr\" \/><\/b>\u062a\u064f\u0637\u0648\u0651\u0631 \u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633 \u0639\u0644\u0627\u062c\u0627\u062a \u0628\u0635\u0631\u064a\u0629 \u0648\u0631\u0627\u062b\u064a\u0629 \u0644\u0627 \u062a\u062a\u0623\u062b\u0631 \u0628\u0627\u0644\u0637\u0641\u0631\u0627\u062a\u060c \u0648\u062a\u064f\u0639\u064a\u062f \u0627\u0644\u0628\u0635\u0631 \u0644\u0645\u0644\u0627\u064a\u064a\u0646 \u0627\u0644\u0645\u0631\u0636\u0649 \u0627\u0644\u0630\u064a\u0646 \u0641\u0642\u062f\u0648\u0627 \u0628\u0635\u0631\u0647\u0645 \u0628\u0633\u0628\u0628 \u0623\u0645\u0631\u0627\u0636 \u062a\u0646\u0643\u0633\u064a\u0629 \u0641\u064a \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0644\u0627 \u064a\u0648\u062c\u062f \u0644\u0647\u0627 \u0639\u0644\u0627\u062c \u062d\u0627\u0644\u064a\u064b\u0627. \u0628\u0639\u062f \u0627\u0644\u0646\u062a\u0627\u0626\u062c \u0627\u0644\u0625\u064a\u062c\u0627\u0628\u064a\u0629 \u0641\u064a \u0646\u0647\u0627\u064a\u0629 \u0627\u0644\u062f\u0631\u0627\u0633\u0629 \u0645\u0646 \u062a\u062c\u0631\u0628\u0629 \u0631\u064a\u0633\u062a\u0648\u0631 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629 \u0645\u062a\u0639\u062f\u062f\u0629 \u0627\u0644\u0645\u0631\u0627\u0643\u0632\u060c \u0627\u0644\u0639\u0634\u0648\u0627\u0626\u064a\u0629\u060c \u0645\u0632\u062f\u0648\u062c\u0629 \u0627\u0644\u062a\u0639\u0645\u064a\u0629\u060c \u0627\u0644\u0645\u064f\u062d\u0643\u0645\u0629 \u0628\u0634\u0643\u0644 \u0648\u0647\u0645\u064a\u060c \u0627\u0644\u0645\u0631\u062d\u0644\u0629 2\u0628\u060c \u0644\u0639\u0644\u0627\u062c \u0627\u0639\u062a\u0644\u0627\u0644 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0635\u0628\u0627\u063a\u064a (<a href=\"https:\/\/clinicaltrials.gov\/study\/NCT04945772\" target=\"_blank\" rel=\"nofollow noopener\">NCT04945772<\/a>)\u060c \u0623\u0639\u0644\u0646\u062a \u0627\u0644\u0634\u0631\u0643\u0629 \u0639\u0646 \u062e\u0637\u062a\u0647\u0627 \u0644\u0628\u062f\u0621\u00a0<a href=\"https:\/\/nanostherapeutics.com\/ar\/2024\/10\/10\/nanoscope-announces-plans-to-submit-bla-for-mco-010-to-treat-retinitis-pigmentosa\/\" target=\"_blank\" rel=\"nofollow noopener\">\u062a\u0642\u062f\u064a\u0645 \u0637\u0644\u0628 \u062a\u0631\u062e\u064a\u0635 BLA \u0644\u0640 MCO-010 \u0644\u0639\u0644\u0627\u062c RP<\/a>\u00a0\u0641\u064a \u0639\u0627\u0645 2025. \u0623\u0643\u0645\u0644\u062a \u0627\u0644\u0634\u0631\u0643\u0629 \u0627\u0644\u0645\u0631\u062d\u0644\u0629 \u0627\u0644\u062b\u0627\u0646\u064a\u0629 \u0645\u0646 \u062a\u062c\u0631\u0628\u0629 STARLIGHT \u0644\u0639\u0644\u0627\u062c MCO-010 \u0644\u0645\u0631\u0636\u0649 \u0633\u062a\u0627\u0631\u063a\u0627\u0631\u062f\u062a (<a href=\"https:\/\/clinicaltrials.gov\/study\/NCT05417126\" target=\"_blank\" rel=\"nofollow noopener\">NCT05417126<\/a>) \u0648\u062a\u062e\u0637\u0637 \u0644\u0628\u062f\u0621\u00a0<a href=\"https:\/\/nanostherapeutics.com\/ar\/2024\/09\/12\/nanoscope-therapeutics-announces-end-of-phase-2-meeting-with-u-s-fda-and-plan-to-initiate-a-phase-3-clinical-trial-of-mco-010-to-treat-stargardt-macular-degeneration\/\" target=\"_blank\" rel=\"nofollow noopener\">\u0627\u0644\u0645\u0631\u062d\u0644\u0629 \u0627\u0644\u062b\u0627\u0644\u062b\u0629 \u0645\u0646 \u0627\u0644\u062a\u062c\u0631\u0628\u0629 \u0627\u0644\u062a\u0633\u062c\u064a\u0644\u064a\u0629<\/a>, \u0623\u064a\u0636\u064b\u0627 \u0641\u064a \u0639\u0627\u0645 2025. \u062d\u0635\u0644 MCO-010 \u0639\u0644\u0649 \u062a\u0635\u0646\u064a\u0641\u0627\u062a \u0627\u0644\u0645\u0633\u0627\u0631 \u0627\u0644\u0633\u0631\u064a\u0639 \u0645\u0646 \u0625\u062f\u0627\u0631\u0629 \u0627\u0644\u063a\u0630\u0627\u0621 \u0648\u0627\u0644\u062f\u0648\u0627\u0621 \u0627\u0644\u0623\u0645\u0631\u064a\u0643\u064a\u0629 \u0648\u062a\u0635\u0646\u064a\u0641\u0627\u062a \u0627\u0644\u0623\u062f\u0648\u064a\u0629 \u0627\u0644\u064a\u062a\u064a\u0645\u0629 \u0644\u0643\u0644 \u0645\u0646 \u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0635\u0628\u0627\u063a\u064a \u0648\u0645\u0631\u0636 \u0633\u062a\u0627\u0631\u063a\u0627\u0631\u062f\u062a. \u062a\u0634\u0645\u0644 \u0627\u0644\u0628\u0631\u0627\u0645\u062c \u0645\u0627 \u0642\u0628\u0644 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629 \u062f\u0648\u0627\u0621 MCO-020 \u063a\u064a\u0631 \u0627\u0644\u0641\u064a\u0631\u0648\u0633\u064a \u0627\u0644\u0630\u064a \u064a\u062a\u0645 \u062a\u0648\u0635\u064a\u0644\u0647 \u0628\u0627\u0644\u0644\u064a\u0632\u0631 \u0648\u0627\u0644\u0645\u062c\u0647\u0632 \u0644\u062a\u0642\u062f\u064a\u0645 \u0637\u0644\u0628 \u062f\u0648\u0627\u0621 \u062c\u062f\u064a\u062f \u0644\u0639\u0644\u0627\u062c \u0636\u0645\u0648\u0631 \u0627\u0644\u0634\u0628\u0643\u064a\u0629\u060c \u0628\u0627\u0644\u0625\u0636\u0627\u0641\u0629 \u0625\u0644\u0649 \u062f\u0648\u0627\u0621 AAV \u0644\u0639\u0644\u0627\u062c \u0627\u0644\u0639\u0645\u0649 \u0627\u0644\u062e\u0644\u0642\u064a \u0644\u0644\u064a\u0628\u0631\u060c \u0648\u0627\u0644\u0630\u064a \u064a\u062e\u0636\u0639 \u062d\u0627\u0644\u064a\u064b\u0627 \u0644\u062f\u0631\u0627\u0633\u0627\u062a \u062a\u0645\u0647\u064a\u062f\u064a\u0629 \u0644\u062a\u0642\u062f\u064a\u0645 \u0637\u0644\u0628 \u062f\u0648\u0627\u0621 \u062c\u062f\u064a\u062f.<\/p>\n<p><b>\u0627\u0644\u0627\u062a\u0635\u0627\u0644 \u0628\u0627\u0644\u0645\u0633\u062a\u062b\u0645\u0631:<\/b><br class=\"dnr\" \/>\u0639\u0644\u0627\u062c\u0627\u062a \u0627\u0644\u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628<br class=\"dnr\" \/>(817) 857-1186<br class=\"dnr\" \/><a href=\"mailto:PR@nanostherapeutics.com\" target=\"_blank\" rel=\"nofollow noopener\">PR@nanostherapeutics.com<\/a><\/p>\n<p>\u0627\u0644\u0645\u0635\u062f\u0631 \u0639\u0644\u0627\u062c\u0627\u062a \u0627\u0644\u0646\u0627\u0646\u0648<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Presentations will highlight durability, efficacy and safety of\u00a0Nanoscope&#8217;s optogenetic therapy platforms DALLAS,\u00a0May 12, 2025\u00a0\/PRNewswire\/ &#8212;\u00a0Nanoscope Therapeutics Inc., a biotech company committed to restoring vision in blind patients in real-world settings by developing and commercializing novel gene therapies for retinal degenerative diseases, today announced multiple presentations at the 28th\u00a0annual meeting of the American Society of Gene [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":7181,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-7237","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanoscope Therapeutics to Present Groundbreaking Research at ASGCT 2025 Annual Meeting - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ar\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"ar_AR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics to Present Groundbreaking Research at ASGCT 2025 Annual Meeting - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ar\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-02T23:20:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-13T20:09:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 \u062f\u0642\u0627\u0626\u0642\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Therapeutics to Present Groundbreaking Research at ASGCT 2025 Annual Meeting\",\"datePublished\":\"2025-07-02T23:20:55+00:00\",\"dateModified\":\"2025-07-13T20:09:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/\"},\"wordCount\":567,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/NSCOPE_ASGCT_LI_2025FEATURE-scaled-1.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ar\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/\",\"name\":\"Nanoscope Therapeutics to Present Groundbreaking Research at ASGCT 2025 Annual Meeting - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/NSCOPE_ASGCT_LI_2025FEATURE-scaled-1.jpg\",\"datePublished\":\"2025-07-02T23:20:55+00:00\",\"dateModified\":\"2025-07-13T20:09:02+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/NSCOPE_ASGCT_LI_2025FEATURE-scaled-1.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/NSCOPE_ASGCT_LI_2025FEATURE-scaled-1.jpg\",\"width\":2560,\"height\":2560},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics to Present Groundbreaking Research at ASGCT 2025 Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ar\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633 \u0633\u062a\u0639\u0631\u0636 \u0623\u0628\u062d\u0627\u062b\u064b\u0627 \u0631\u0627\u0626\u062f\u0629 \u0641\u064a \u0627\u0644\u0627\u062c\u062a\u0645\u0627\u0639 \u0627\u0644\u0633\u0646\u0648\u064a \u0644\u0644\u062c\u0645\u0639\u064a\u0629 \u0627\u0644\u0623\u0645\u0631\u064a\u0643\u064a\u0629 \u0644\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u0643\u064a\u0645\u064a\u0627\u0626\u064a \u0648\u0627\u0644\u062e\u0644\u0648\u064a 2025 - \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633","description":"\u062a\u064f\u0639\u062f\u0651 \u0645\u0646\u0635\u0629 \u0627\u0644\u0623\u0648\u0628\u0633\u064a\u0646 \u0645\u062a\u0639\u062f\u062f\u0629 \u0627\u0644\u062e\u0635\u0627\u0626\u0635 (MCO) \u0627\u0644\u062e\u0627\u0635\u0629 \u0628\u0646\u0627 \u0627\u0644\u0623\u0648\u0644\u0649 \u0645\u0646 \u0646\u0648\u0639\u0647\u0627 \u0627\u0644\u062a\u064a \u0623\u062b\u0628\u062a\u062a \u0642\u062f\u0631\u062a\u0647\u0627 \u0639\u0644\u0649 \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631 \u0644\u0645\u0631\u0636\u0649 \u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0630\u064a\u0646 \u064a\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u0641\u0642\u062f\u0627\u0646 \u0634\u062f\u064a\u062f \u0644\u0644\u0628\u0635\u0631 \u0641\u064a \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629. \u0648\u0642\u062f \u0637\u0648\u0651\u0631\u062a \u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062a\u0642\u0646\u064a\u0629 MCO-010\u060c \u0648\u0647\u064a \u0627\u0644\u062a\u0642\u0646\u064a\u0629 \u0627\u0644\u0623\u0648\u0644\u0649 \u0648\u0627\u0644\u0648\u062d\u064a\u062f\u0629 \u0645\u0646 \u0646\u0648\u0639\u0647\u0627 \u0641\u064a \u0645\u062c\u0627\u0644 \u0639\u0644\u0645 \u0627\u0644\u0628\u0635\u0631\u064a\u0627\u062a \u0627\u0644\u0648\u0631\u0627\u062b\u064a\u0629\u060c \u0648\u0627\u0644\u062a\u064a \u062a\u062a\u0645\u064a\u0632 \u0628\u0646\u0637\u0627\u0642\u0647\u0627 \u0627\u0644\u0648\u0627\u0633\u0639 \u0648\u0627\u0633\u062a\u062c\u0627\u0628\u062a\u0647\u0627 \u0627\u0644\u0633\u0631\u064a\u0639\u0629 \u0648\u062d\u0633\u0627\u0633\u064a\u062a\u0647\u0627 \u0627\u0644\u0641\u0627\u0626\u0642\u0629\u060c \u0648\u0647\u064a \u062a\u0642\u0646\u064a\u0629 \u0645\u0633\u062a\u0642\u0644\u0629 \u0639\u0646 \u0627\u0644\u062c\u064a\u0646\u0627\u062a \u0627\u0644\u0645\u0633\u062a\u062e\u062f\u0645\u0629 \u0641\u064a \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ar\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/","og_locale":"ar_AR","og_type":"article","og_title":"Nanoscope Therapeutics to Present Groundbreaking Research at ASGCT 2025 Annual Meeting - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ar\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2025-07-02T23:20:55+00:00","article_modified_time":"2025-07-13T20:09:02+00:00","og_image":[{"width":1200,"height":242,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629":"Nanoscope Therapeutics","\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631":"3 \u062f\u0642\u0627\u0626\u0642"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Therapeutics to Present Groundbreaking Research at ASGCT 2025 Annual Meeting","datePublished":"2025-07-02T23:20:55+00:00","dateModified":"2025-07-13T20:09:02+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/"},"wordCount":567,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/05\/NSCOPE_ASGCT_LI_2025FEATURE-scaled-1.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ar"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/","url":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/","name":"\u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633 \u0633\u062a\u0639\u0631\u0636 \u0623\u0628\u062d\u0627\u062b\u064b\u0627 \u0631\u0627\u0626\u062f\u0629 \u0641\u064a \u0627\u0644\u0627\u062c\u062a\u0645\u0627\u0639 \u0627\u0644\u0633\u0646\u0648\u064a \u0644\u0644\u062c\u0645\u0639\u064a\u0629 \u0627\u0644\u0623\u0645\u0631\u064a\u0643\u064a\u0629 \u0644\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u0643\u064a\u0645\u064a\u0627\u0626\u064a \u0648\u0627\u0644\u062e\u0644\u0648\u064a 2025 - \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/05\/NSCOPE_ASGCT_LI_2025FEATURE-scaled-1.jpg","datePublished":"2025-07-02T23:20:55+00:00","dateModified":"2025-07-13T20:09:02+00:00","description":"\u062a\u064f\u0639\u062f\u0651 \u0645\u0646\u0635\u0629 \u0627\u0644\u0623\u0648\u0628\u0633\u064a\u0646 \u0645\u062a\u0639\u062f\u062f\u0629 \u0627\u0644\u062e\u0635\u0627\u0626\u0635 (MCO) \u0627\u0644\u062e\u0627\u0635\u0629 \u0628\u0646\u0627 \u0627\u0644\u0623\u0648\u0644\u0649 \u0645\u0646 \u0646\u0648\u0639\u0647\u0627 \u0627\u0644\u062a\u064a \u0623\u062b\u0628\u062a\u062a \u0642\u062f\u0631\u062a\u0647\u0627 \u0639\u0644\u0649 \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631 \u0644\u0645\u0631\u0636\u0649 \u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0630\u064a\u0646 \u064a\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u0641\u0642\u062f\u0627\u0646 \u0634\u062f\u064a\u062f \u0644\u0644\u0628\u0635\u0631 \u0641\u064a \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629. \u0648\u0642\u062f \u0637\u0648\u0651\u0631\u062a \u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062a\u0642\u0646\u064a\u0629 MCO-010\u060c \u0648\u0647\u064a \u0627\u0644\u062a\u0642\u0646\u064a\u0629 \u0627\u0644\u0623\u0648\u0644\u0649 \u0648\u0627\u0644\u0648\u062d\u064a\u062f\u0629 \u0645\u0646 \u0646\u0648\u0639\u0647\u0627 \u0641\u064a \u0645\u062c\u0627\u0644 \u0639\u0644\u0645 \u0627\u0644\u0628\u0635\u0631\u064a\u0627\u062a \u0627\u0644\u0648\u0631\u0627\u062b\u064a\u0629\u060c \u0648\u0627\u0644\u062a\u064a \u062a\u062a\u0645\u064a\u0632 \u0628\u0646\u0637\u0627\u0642\u0647\u0627 \u0627\u0644\u0648\u0627\u0633\u0639 \u0648\u0627\u0633\u062a\u062c\u0627\u0628\u062a\u0647\u0627 \u0627\u0644\u0633\u0631\u064a\u0639\u0629 \u0648\u062d\u0633\u0627\u0633\u064a\u062a\u0647\u0627 \u0627\u0644\u0641\u0627\u0626\u0642\u0629\u060c \u0648\u0647\u064a \u062a\u0642\u0646\u064a\u0629 \u0645\u0633\u062a\u0642\u0644\u0629 \u0639\u0646 \u0627\u0644\u062c\u064a\u0646\u0627\u062a \u0627\u0644\u0645\u0633\u062a\u062e\u062f\u0645\u0629 \u0641\u064a \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/#breadcrumb"},"inLanguage":"ar","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/05\/NSCOPE_ASGCT_LI_2025FEATURE-scaled-1.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/05\/NSCOPE_ASGCT_LI_2025FEATURE-scaled-1.jpg","width":2560,"height":2560},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics to Present Groundbreaking Research at ASGCT 2025 Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u0639\u0644\u0627\u062c\u0627\u062a \u0627\u0644\u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628","description":"\u0625\u0639\u0627\u062f\u0629 \u0646\u0648\u0631 \u0627\u0644\u0623\u0645\u0644","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ar"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u0639\u0644\u0627\u062c\u0627\u062a \u0627\u0644\u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/posts\/7237","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/comments?post=7237"}],"version-history":[{"count":1,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/posts\/7237\/revisions"}],"predecessor-version":[{"id":7559,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/posts\/7237\/revisions\/7559"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/media\/7181"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/media?parent=7237"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/categories?post=7237"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/tags?post=7237"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}